CN103006942B - Traditional Chinese medicine for treating osteoporosis by utilizing acer mono - Google Patents
Traditional Chinese medicine for treating osteoporosis by utilizing acer mono Download PDFInfo
- Publication number
- CN103006942B CN103006942B CN201210508001.8A CN201210508001A CN103006942B CN 103006942 B CN103006942 B CN 103006942B CN 201210508001 A CN201210508001 A CN 201210508001A CN 103006942 B CN103006942 B CN 103006942B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- acer mono
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating osteoporosis by utilizing acer mono. The traditional Chinese medicine comprises the following raw materials in parts by weight: 13-17 parts of lumbricus, 6-10 parts of trichosanthes palmate, 8-12 parts of ardisia villosa, 6-10 parts of ficus tikoua, 13-17 parts of acer mono, 8-12 parts of herba epimedii, 4-8 parts of astragalus mongholicus, 1-5 parts of ginseng, 8-12 parts of eucommia ulmoides, 6-10 parts of glossy privet fruit, 6-10 parts of Chinese herbaceous peony, 13-17 parts of caulis spatholobi, 4-8 parts of mulberry, 6-10 parts of pollen typhae, 4-8 parats of lycopodium clavatum and 8-12 parts of obscured homalomena rhizome. The formula of the traditional Chinese medicine utilizes the characteristic of promoting blood circulation to arrest pain of the acer mono, and is matched with the traditional Chinese medicine formula for nourishing yin and blood, strengthening tendons and bones and clearing and activating the channels and collaterals, so that the pain of a patient can be alleviated effectively, the absorption and the utilization of calcium can be promoted, the side and toxic effects are low, and the medicine is safe.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, particularly relates to one and utilizes Acer mono Maxim. to treat osteoporotic Chinese medicine.
background technology:
Osteoporosis (osteoporosis) is one group of osteopathia that many reasons causes, and osseous tissue has normal calcification, and calcium salt and substrate are normal rates, and the metabolic osteopathy being reduced to feature with unit volume inner bone tissues amount becomes.In most osteoporosis, caused by the minimizing of osseous tissue increases mainly due to bone absorption.Fall ill how slowly indivedual very fast, with skeleton pain, be easy to fracture for feature biochemical analysis is normal.
At present, the treatment for primary disease mainly relies on Drug therapy, substantially comprises estrogen replacement therapy, calcitonin and calcium preparation etc.These medicines are mostly expensive, and have comparatively significantly side effect.And have and close report, life-time service estrogen has the possibility of bringing out breast carcinoma.Due to the difference of patient's calcium absorption ability, calcitonin and calcium preparation curative effect unsatisfactory, and other therapies can only as auxiliary therapy.
Therefore, at present, the sickness rate of clinical osteoporosis is very high, but lacks medicine safely and effectively, and the medicine actively developing treatment osteoporosis is very necessary.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, provides one to utilize Acer mono Maxim. to treat osteoporotic Chinese medicine, it can effectively pain relieving, reduction of patient painful, promote that patient is to the absorption of calcium and utilization.
The present invention is achieved by the following technical solutions:
One utilizes Acer mono Maxim. to treat osteoporotic Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Pheretima 13-17, Radix Stephaniae Cepharanthae 6-10, the red 8-12 that snows, Caulis et Folium fici Tikouae 6-10, Acer mono Maxim. 13-17, Herba Epimedii 8-12, Radix Astragali 4-8, Radix Ginseng 1-5, Cortex Eucommiae 8-12, Fructus Ligustri Lucidi 6-10, Radix Paeoniae 6-10, Caulis Spatholobi 13-17, Fructus Mori 4-8, Pollen Typhae 6-10, Herba Lycopodii 4-8, Rhizoma Homalomenae 8-12.
One utilizes Acer mono Maxim. to treat osteoporotic Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Pheretima 15, Radix Stephaniae Cepharanthae 8, snow red 10, Caulis et Folium fici Tikouae 8, Acer mono Maxim. 15, Herba Epimedii 10, the Radix Astragali 6, Radix Ginseng 3, the Cortex Eucommiae 10, Fructus Ligustri Lucidi 8, Radix Paeoniae 8, Caulis Spatholobi 15, Fructus Mori 6, Pollen Typhae 8, Herba Lycopodii 6, Rhizoma Homalomenae 10.
Acer mono Maxim.: [nature and flavor] are pungent; Bitter; Temperature.[function cures mainly] expelling wind and removing dampness; Promoting blood circulation and stopping pain.Main migraine and general headache; Anemofrigid-damp arthralgia; Traumatic injury stasis of blood pain; Eczema; Scabies.
Advantage of the present invention is:
Formula of the present invention utilizes the characteristic of Acer mono Maxim. promoting blood circulation and stopping pain, coordinates the Chinese medicine formula that nourishing YIN and supplementing blood, strengthening the tendons and bones, dysmenorrhea are active, can the pain of effective reduction of patient, and the absorption of promotion calcium and utilization, toxic and side effects is little, drug safety.
detailed description of the invention:
One utilizes Acer mono Maxim. to treat osteoporotic Chinese medicine, and the weight (g) of its each raw material components is: Pheretima 15, Radix Stephaniae Cepharanthae 8, snow red 10, Caulis et Folium fici Tikouae 8, Acer mono Maxim. 15, Herba Epimedii 10, the Radix Astragali 6, Radix Ginseng 3, the Cortex Eucommiae 10, Fructus Ligustri Lucidi 8, Radix Paeoniae 8, Caulis Spatholobi 15, Fructus Mori 6, Pollen Typhae 8, Herba Lycopodii 6, Rhizoma Homalomenae 10.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case one:
Money, man, 49 years old.Main suit: patient was because of general aching 6 months, and the migrans pain in the whole body, soreness of the waist and knees, spirit is not good, appetite is poor.To hospital: bone densitometry :-2.8, be diagnosed as: osteoporosis.Give treatment by Chinese herbs of the present invention, after taking one week, patient pain is alleviated, and spirit improves; Continue to take one month, patient gets well.
Case two:
Zhao, female, 71 years old.Main suit: lumbago and backache 3 years repeatedly, increases the weight of March, occurs obvious lumbago and backache, with breast waist Duan Weizhu, handicapped, day by day becomes thin.X-ray film shows T11, T12, L2 compression fracture.Be diagnosed as: osteoporosis.Give treatment by Chinese herbs of the present invention, after taking first quarter moon, patient's pain in the lumbar region is alleviated to some extent, and basic activity is accessible; Continue to take 50 days, patient gets well, freedom of movement.
Case three:
Profound certain, patient, female, 38 years old.Main suit: lumbago April, increase the weight of companion's movable difficulty January, bending over, the pain increased.X-ray photographing reminding vertebral body T6, T7, L1 compression fracture.Be diagnosed as: osteoporosis.Give treatment by Chinese herbs of the present invention, after taking first quarter moon, patient's pain in the lumbar region is alleviated to some extent, and basic activity is accessible; Continue to take 2 months, patient gets well.
Claims (2)
1. utilize Acer mono Maxim. to treat an osteoporotic Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Pheretima 13-17, Radix Stephaniae Cepharanthae 6-10, the red 8-12 that snows, Caulis et Folium fici Tikouae 6-10, Acer mono Maxim. 13-17, Herba Epimedii 8-12, Radix Astragali 4-8, Radix Ginseng 1-5, Cortex Eucommiae 8-12, Fructus Ligustri Lucidi 6-10, Radix Paeoniae 6-10, Caulis Spatholobi 13-17, Fructus Mori 4-8, Pollen Typhae 6-10, Herba Lycopodii 4-8, Rhizoma Homalomenae 8-12.
2. one according to claim 1 utilizes Acer mono Maxim. to treat osteoporotic Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Pheretima 15, Radix Stephaniae Cepharanthae 8, snow red 10, Caulis et Folium fici Tikouae 8, Acer mono Maxim. 15, Herba Epimedii 10, the Radix Astragali 6, Radix Ginseng 3, the Cortex Eucommiae 10, Fructus Ligustri Lucidi 8, Radix Paeoniae 8, Caulis Spatholobi 15, Fructus Mori 6, Pollen Typhae 8, Herba Lycopodii 6, Rhizoma Homalomenae 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210508001.8A CN103006942B (en) | 2012-12-03 | 2012-12-03 | Traditional Chinese medicine for treating osteoporosis by utilizing acer mono |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210508001.8A CN103006942B (en) | 2012-12-03 | 2012-12-03 | Traditional Chinese medicine for treating osteoporosis by utilizing acer mono |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103006942A CN103006942A (en) | 2013-04-03 |
| CN103006942B true CN103006942B (en) | 2015-04-22 |
Family
ID=47956405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210508001.8A Expired - Fee Related CN103006942B (en) | 2012-12-03 | 2012-12-03 | Traditional Chinese medicine for treating osteoporosis by utilizing acer mono |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103006942B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
| CN1785282A (en) * | 2005-11-28 | 2006-06-14 | 蓝子花 | Caragana network vessel quickening dampness damage pain relieving plaster |
| CN101780243A (en) * | 2010-03-30 | 2010-07-21 | 豆坤 | Combined medicament for treating rheumatism and preparation method thereof |
| CN102327471A (en) * | 2011-09-16 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | Chinese herbal medicine for treating arthralgia induced by yin deficiency, hyperactivity of yang, qi deficiency and liver stagnation |
| CN102727719A (en) * | 2012-05-16 | 2012-10-17 | 万晓峰 | External application Chinese herbal for treating protruded disc, slipped disk, prolapsed disk and hyperosteogeny |
| CN102793868A (en) * | 2012-08-27 | 2012-11-28 | 王永刚 | Preparation method of traditional Chinese medicine lotion for treating rapid respiration type closed fracture |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1176800A (en) * | 1996-09-13 | 1998-03-25 | 唐山钢铁集团有限责任公司 | Method for preparing expelling wind and strengthening the bone medicated wine |
-
2012
- 2012-12-03 CN CN201210508001.8A patent/CN103006942B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
| CN1785282A (en) * | 2005-11-28 | 2006-06-14 | 蓝子花 | Caragana network vessel quickening dampness damage pain relieving plaster |
| CN101780243A (en) * | 2010-03-30 | 2010-07-21 | 豆坤 | Combined medicament for treating rheumatism and preparation method thereof |
| CN102327471A (en) * | 2011-09-16 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | Chinese herbal medicine for treating arthralgia induced by yin deficiency, hyperactivity of yang, qi deficiency and liver stagnation |
| CN102727719A (en) * | 2012-05-16 | 2012-10-17 | 万晓峰 | External application Chinese herbal for treating protruded disc, slipped disk, prolapsed disk and hyperosteogeny |
| CN102793868A (en) * | 2012-08-27 | 2012-11-28 | 王永刚 | Preparation method of traditional Chinese medicine lotion for treating rapid respiration type closed fracture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103006942A (en) | 2013-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178901B (en) | Medicament for treating uterus cancer | |
| CN102641434A (en) | Capsule capable of promoting blood circulation, removing meridian obstruction and removing paralysis and preparing technology thereof | |
| CN105079184A (en) | Medicine for treating osteoporosis | |
| CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN103251865A (en) | Traditional Chinese medicine composite for treating diarrhea | |
| CN103006942B (en) | Traditional Chinese medicine for treating osteoporosis by utilizing acer mono | |
| CN101422547B (en) | Traditional Chinese medicine for treating kidney-deficiency blood-insufficiency type amenorrhea | |
| CN103191315B (en) | Traditional Chinese medicine for treating postmenopausal osteoporosis | |
| CN102349949B (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
| CN105770251A (en) | Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis | |
| CN104645223A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN103006853B (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
| CN101953908A (en) | Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN103182037A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN1879811B (en) | Chinese medicinal composition for treating epilepsy | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN101584839A (en) | Chinese medicament for treating acute and chronic cholecystitis | |
| CN103028062B (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN104666469A (en) | Traditional Chinese medicine composition for treating phase III shoulder-hand syndrome | |
| CN103110852B (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN101983653B (en) | Drug for treating lumbocrural pain and preparation method thereof | |
| CN105999139A (en) | Traditional Chinese medicine composition for treating hypermenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20161203 |